Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Clinical trial NCT01197885 · COMPLETED
Trial details
- NCT number
- NCT01197885
- Sponsor
- Ganymed Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-03
- Primary completion
- 2015-08-13
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.